FMP
PTC Therapeutics, Inc.
PTCT
NASDAQ
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States, as well as to treat nonsense mutation Duchenne muscular dystrophy in Brazil and Russia; commercializes Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean; and markets Evrysdi for the treatment of spinal muscular atrophy in adults and children two months and older in Brazil. The company's splicing platform includes PTC518, which is being developed for the treatment of Huntington's disease. PTC Therapeutics, Inc. has collaborations with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., as well as the Spinal Muscular Atrophy Foundation to advance drug discovery and development research in regenerative medicine; and Akcea Therapeutics, Inc. to commercialize Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.
57.17 USD
2.67 (4.67%)
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
34.03M
72.83M
46.83M
78.59M
47.07M
57.9M
71.22M
87.61M
107.76M
132.56M
-
114
-35.71
67.84
-40.11
23.01
23.01
23.01
23.01
88.13M
-128.95M
-153.09M
-102.83M
-194.5M
-34.74M
-42.73M
-52.57M
-64.66M
-79.53M
258.95
-177.05
-326.92
-130.84
-413.2
-60
-60
-60
-60
-9.1M
-1.6M
-2.84M
-34.48M
-12.84M
-12.29M
-15.12M
-18.59M
-22.87M
-28.13M
-26.73
-2.19
-6.06
-43.87
-27.27
-21.22
-21.22
-21.22
-21.22
79.03M
-130.54M
-155.92M
-137.31M
-207.34M
-47.03M
-57.85M
-71.16M
-87.53M
-107.67M
34.49
75.04M
4.11
4.11
87.76M
2.59B
2.68B
3.28
96.72
14.27
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
34.03M
72.83M
46.83M
78.59M
47.07M
57.9M
71.22M
87.61M
107.76M
132.56M
88.13M
-128.95M
-153.09M
-102.83M
-194.5M
-34.74M
-42.73M
-52.57M
-64.66M
-79.53M
-9.1M
-1.6M
-2.84M
-34.48M
-12.84M
-12.29M
-15.12M
-18.59M
-22.87M
-28.13M
79.03M
-130.54M
-155.92M
-137.31M
-207.34M
-47.03M
-57.85M
-71.16M
-87.53M
-107.67M
14.27
14.27
14.27
14.27
14.27
-41.16M
-44.3M
-47.68M
-51.33M
-55.25M
-239.72M
14.27
-109.82M
-894.7M
-459.12M
-698.84M
-32.49M
-666.35M
75.04M
-8.88
-8.88 4.884%